Approval · Notice of Compliance 3027 · 1998
EMLA: Notice of Compliance 3027
Issued May 4, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3027
- Date
- May 4, 1998
- Company
- Astra Pharma Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Provides for use of the non-sterile cream for leg ulcers and change in frequency of treatment
- Therapeutic class
- Topical anesthetic for dermal anlagesia
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EMLA | Not yet assigned | — |
Medicinal ingredients
- LIDOCAINE 25 MG per G
- PRILOCAINE 25 MG per G